Cargando…
Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention
In 2019/2020, the emergence of coronavirus disease 2019 (COVID‐19) resulted in rapid increases in infection rates as well as patient mortality. Treatment options addressing COVID‐19 included drug repurposing, investigational therapies such as remdesivir, and vaccine development. Combination therapy...
Autores principales: | Abdulla, Aynur, Wang, Boqian, Qian, Feng, Kee, Theodore, Blasiak, Agata, Ong, Yoong Hun, Hooi, Lissa, Parekh, Falgunee, Soriano, Rafael, Olinger, Gene G., Keppo, Jussi, Hardesty, Chris L., Chow, Edward K., Ho, Dean, Ding, Xianting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235487/ https://www.ncbi.nlm.nih.gov/pubmed/32838027 http://dx.doi.org/10.1002/adtp.202000034 |
Ejemplares similares
-
Addressing antimicrobial resistance with the IDentif.AI platform: Rapidly optimizing clinically actionable combination therapy regimens against nontuberculous mycobacteria
por: Mukherjee, Devika, et al.
Publicado: (2022) -
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development
por: Blasiak, Agata, et al.
Publicado: (2020) -
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens
por: Blasiak, Agata, et al.
Publicado: (2022) -
Harnessing the Potential of AI for Indico.AI
por: Vohra, Vasant
Publicado: (2023) -
Climate change and infectious disease: A prologue on multidisciplinary cooperation and predictive analytics
por: Yeh, Kenneth B., et al.
Publicado: (2023)